These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7905747)

  • 1. Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
    Wigler PW; Patterson FK
    Biochim Biophys Acta; 1994 Jan; 1189(1):1-6. PubMed ID: 7905747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
    Wigler PW; Lyon KL; Patterson FK; La Loggia AJ; Diaz-Araúzo H; Reddy MS; Cook JM
    Mol Pharmacol; 1994 Sep; 46(3):562-7. PubMed ID: 7935339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular drug efflux and reversal therapy of cancer.
    Wigler PW
    J Bioenerg Biomembr; 1996 Jun; 28(3):279-84. PubMed ID: 8807402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the multidrug resistance efflux pump.
    Wigler PW; Patterson FK
    Biochim Biophys Acta; 1993 Oct; 1154(2):173-81. PubMed ID: 8105892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
    Altenberg GA; Vanoye CG; Han ES; Deitmer JW; Reuss L
    J Biol Chem; 1994 Mar; 269(10):7145-9. PubMed ID: 7510282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
    Wigler PW
    Biochem Biophys Res Commun; 1999 Apr; 257(2):410-3. PubMed ID: 10198227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells.
    Weaver JL; Pine PS; Aszalos A; Schoenlein PV; Currier SJ; Padmanabhan R; Gottesman MM
    Exp Cell Res; 1991 Oct; 196(2):323-9. PubMed ID: 1680064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of P glycoprotein activity on normal and leukemic CD34+ cells.
    Drenou B; Fardel O; Amiot L; Fauchet R
    Leuk Res; 1993 Dec; 17(12):1031-5. PubMed ID: 7504150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid stimulation of rhodamine 123 efflux from multidrug-resistant KB cells by progesterone.
    Jancis EM; Chen HX; Carbone R; Hochberg RB; Dannies PS
    Biochem Pharmacol; 1993 Nov; 46(9):1613-9. PubMed ID: 7902090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of mitomycin C-induced multidrug resistance in vitro.
    Dorr RT; Liddil JD
    Cancer Chemother Pharmacol; 1991; 27(4):290-4. PubMed ID: 1671830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rhodamine 123 uptake by nigericin in sensitive and multidrug resistant leukemic cells.
    Canitrot Y; Lautier D; Viallet P; Salmon JM
    Cancer Lett; 1994 Aug; 84(1):75-83. PubMed ID: 8076364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells.
    Ehring GR; Osipchuk YV; Cahalan MD
    J Gen Physiol; 1994 Dec; 104(6):1129-61. PubMed ID: 7699367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
    Altenberg GA; Vanoye CG; Horton JK; Reuss L
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of rhodamine 123 for the detection of multidrug resistance].
    Canitrot Y; Lautier D
    Bull Cancer; 1995 Sep; 82(9):687-97. PubMed ID: 8535026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance in cancer cells.
    Wigler PW
    J Natl Cancer Inst; 1994 Jan; 86(2):148-50. PubMed ID: 7903703
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terfenadine (Seldane): a new drug for restoring sensitivity to multidrug resistant cancer cells.
    Hait WN; Gesmonde JF; Murren JR; Yang JM; Chen HX; Reiss M
    Biochem Pharmacol; 1993 Jan; 45(2):401-6. PubMed ID: 8094615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.